Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature.

Polenakovik HM, Pleiman CM.

Int J Antimicrob Agents. 2013 Nov;42(5):450-5. doi: 10.1016/j.ijantimicag.2013.07.005. Epub 2013 Aug 11. Review.

PMID:
23993067
2.

Ceftaroline-induced eosinophilic pneumonia.

Desai KR, Burdette SD, Polenakovik HM, Hagaman J, Pleiman CM.

Pharmacotherapy. 2013 Jul;33(7):e166-9. doi: 10.1002/phar.1286. Epub 2013 May 3.

PMID:
23649990
3.

Discovery of N-methyl-4-(4-methoxyanilino)quinazolines as potent apoptosis inducers. Structure-activity relationship of the quinazoline ring.

Sirisoma N, Pervin A, Zhang H, Jiang S, Adam Willardsen J, Anderson MB, Mather G, Pleiman CM, Kasibhatla S, Tseng B, Drewe J, Cai SX.

Bioorg Med Chem Lett. 2010 Apr 1;20(7):2330-4. doi: 10.1016/j.bmcl.2010.01.155. Epub 2010 Feb 4.

PMID:
20188546
4.

Discovery of N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a potent apoptosis inducer and efficacious anticancer agent with high blood brain barrier penetration.

Sirisoma N, Pervin A, Zhang H, Jiang S, Willardsen JA, Anderson MB, Mather G, Pleiman CM, Kasibhatla S, Tseng B, Drewe J, Cai SX.

J Med Chem. 2009 Apr 23;52(8):2341-51. doi: 10.1021/jm801315b.

PMID:
19296653
5.

Discovery of 2-chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (EP128265, MPI-0441138) as a potent inducer of apoptosis with high in vivo activity.

Sirisoma N, Kasibhatla S, Pervin A, Zhang H, Jiang S, Willardsen JA, Anderson MB, Baichwal V, Mather GG, Jessing K, Hussain R, Hoang K, Pleiman CM, Tseng B, Drewe J, Cai SX.

J Med Chem. 2008 Aug 14;51(15):4771-9. doi: 10.1021/jm8003653. Epub 2008 Jul 24.

PMID:
18651728
6.

MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps.

Kasibhatla S, Baichwal V, Cai SX, Roth B, Skvortsova I, Skvortsov S, Lukas P, English NM, Sirisoma N, Drewe J, Pervin A, Tseng B, Carlson RO, Pleiman CM.

Cancer Res. 2007 Jun 15;67(12):5865-71.

7.

Antitumor activity of CTFB, a novel anticancer agent, is associated with the down-regulation of nuclear factor-kappaB expression and proteasome activation in head and neck squamous carcinoma cell lines.

Skvortsov S, Skvortsova I, Stasyk T, Schiefermeier N, Neher A, Gunkel AR, Bonn GK, Huber LA, Lukas P, Pleiman CM, Zwierzina H.

Mol Cancer Ther. 2007 Jun;6(6):1898-908.

8.

Selective A1-adenosine receptor antagonists identified using yeast Saccharomyces cerevisiae functional assays.

Campbell RM, Cartwright C, Chen W, Chen Y, Duzic E, Fu JM, Loveland M, Manning R, McKibben B, Pleiman CM, Silverman L, Trueheart J, Webb DR, Wilkinson V, Witter DJ, Xie X, Castelhano AL.

Bioorg Med Chem Lett. 1999 Aug 16;9(16):2413-8.

PMID:
10476879
9.

pp56Lck mediates TCR zeta-chain binding to the microfilament cytoskeleton.

Rozdzial MM, Pleiman CM, Cambier JC, Finkel TH.

J Immunol. 1998 Nov 15;161(10):5491-9.

11.

Qualitatively distinct signaling through T cell antigen receptor subunits.

Jensen WA, Pleiman CM, Beaufils P, Wegener AM, Malissen B, Cambier JC.

Eur J Immunol. 1997 Mar;27(3):707-16.

PMID:
9079813
12.

Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases.

Johnson SA, Pleiman CM, Pao L, Schneringer J, Hippen K, Cambier JC.

J Immunol. 1995 Nov 15;155(10):4596-603.

PMID:
7594458
13.

The B-cell antigen receptor complex: structure and signal transduction.

Pleiman CM, D'Ambrosio D, Cambier JC.

Immunol Today. 1994 Sep;15(9):393-9. Review.

PMID:
7945780
14.

Distinct p53/56lyn and p59fyn domains associate with nonphosphorylated and phosphorylated Ig-alpha.

Pleiman CM, Abrams C, Gauen LT, Bedzyk W, Jongstra J, Shaw AS, Cambier JC.

Proc Natl Acad Sci U S A. 1994 May 10;91(10):4268-72.

15.

Activation of phosphatidylinositol-3' kinase by Src-family kinase SH3 binding to the p85 subunit.

Pleiman CM, Hertz WM, Cambier JC.

Science. 1994 Mar 18;263(5153):1609-12.

PMID:
8128248
16.
17.

Signal transduction by the B cell antigen receptor and its coreceptors.

Cambier JC, Pleiman CM, Clark MR.

Annu Rev Immunol. 1994;12:457-86. Review.

PMID:
8011288
19.

A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf.

Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL.

Science. 1993 Apr 16;260(5106):315-9.

PMID:
8385802
20.

Analysis of the fibroblast transformation potential of GTPase-deficient gip2 oncogenes.

Gupta SK, Gallego C, Lowndes JM, Pleiman CM, Sable C, Eisfelder BJ, Johnson GL.

Mol Cell Biol. 1992 Jan;12(1):190-7.

21.

Efficient gene transfer and expression in primary B lymphocytes.

Overell RW, Weisser KE, Hess BW, Ziegler SF, Pleiman CM, Maliszewski C, Grabstein KH.

J Immunol Methods. 1991 Jul 26;141(1):53-62.

PMID:
1865123
22.
23.

Structure and expression of the murine hck gene.

Ziegler SF, Pleiman CM, Perlmutter RM.

Oncogene. 1991 Feb;6(2):283-8.

PMID:
1705689

Supplemental Content

Loading ...
Support Center